TreeWAS – Variant ID: rs1829883

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.000	0.888	0.112
J44 Other chronic obstructive pulmonary disease	0.000	0.943	0.057
J44.9 Chronic obstructive pulmonary disease, unspecified	0.000	0.946	0.054
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.964	0.036
Y42.5 Other oestrogens and progestogens	0.022	0.978	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.021	0.979	0.000
J44.8 Other specified chronic obstructive pulmonary disease	0.000	0.981	0.019
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.019	0.981	0.000
Y42.1 Thyroid hormones and substitutes	0.018	0.982	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.018	0.982	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.018	0.982	0.000
Y42.2 Antithyroid drugs	0.017	0.983	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.984	0.016
Y42.9 Other and unspecified hormone antagonists	0.015	0.985	0.000
Y42.4 Oral contraceptives	0.015	0.985	0.000
Y44.2 Anticoagulants	0.015	0.985	0.000
Y44 Agents primarily affecting blood constituents	0.014	0.986	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.012	0.988	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.012	0.988	0.000
K62.3 Rectal prolapse	0.012	0.988	0.000
Y42.7 Androgens and anabolic congeners	0.012	0.988	0.000
Y44.5 Thrombolytic drugs	0.012	0.988	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.012	0.988	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.012	0.988	0.000
Y46.6 Other and unspecified antiepileptics	0.012	0.988	0.000
Y44.6 Natural blood and blood products	0.011	0.988	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.011	0.989	0.000
Y46.2 Hydantoin derivatives	0.011	0.989	0.000
N93.8 Other specified abnormal uterine and vaginal bleeding	0.011	0.989	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.011	0.989	0.000
C44.1 Skin of eyelid, including canthus	0.011	0.989	0.000
Y59 Other and unspecified vaccines and biological substances	0.010	0.989	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.010	0.990	0.000
Y44.7 Plasma substitutes	0.010	0.990	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.010	0.990	0.000
Y48 Anaesthetics and therapeutic gases	0.010	0.990	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.010	0.990	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.010	0.990	0.000
N94.1 Dyspareunia	0.000	0.990	0.010
Y46.7 Anti-Parkinsonism drugs	0.010	0.990	0.000
Y46.4 Iminostilbenes	0.010	0.990	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.009	0.991	0.000
Y46.8 Antispasticity drugs	0.009	0.991	0.000
Y46.3 Deoxybarbiturates	0.009	0.991	0.000
Y46.1 Oxazolidinediones	0.009	0.991	0.000
Y46.0 Succinimides	0.009	0.991	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.009	0.991	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
Y59.3 Immunoglobulin	0.009	0.991	0.000
Y46.5 Valproic acid	0.009	0.991	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.009	0.991	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.000	0.991	0.009
Y42.0 Glucocorticoids and synthetic analogs	0.009	0.991	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.009	0.991	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.009	0.991	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.009	0.991	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.009	0.991	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.009	0.991	0.000
Y51.0 Anticholinesterase agents	0.009	0.991	0.000
Y48.4 Anaesthetic, unspecified	0.009	0.991	0.000
Y57 Other and unspecified drugs and medicaments	0.009	0.991	0.000
Y58 Bacterial vaccines	0.008	0.991	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.008	0.991	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
Y48.3 Local anaesthetics	0.008	0.992	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.008	0.992	0.000
Y53.2 Stimulant laxatives	0.008	0.992	0.000
Y53.3 Saline and osmotic laxatives	0.008	0.992	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.008	0.992	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.008	0.992	0.000
Y59.9 Vaccine or biological substance, unspecified	0.008	0.992	0.000
Y59.8 Other specified vaccines and biological substances	0.008	0.992	0.000
Y59.2 Protozoal vaccines	0.008	0.992	0.000
Y59.1 Rickettsial vaccines	0.008	0.992	0.000
Y59.0 Viral vaccines	0.008	0.992	0.000
Y53.6 Antidiarrhoeal drugs	0.008	0.992	0.000
Y57.5 X-ray contrast media	0.008	0.992	0.000
Y48.5 Therapeutic gases	0.007	0.992	0.000
Y48.1 Parenteral anaesthetics	0.007	0.992	0.000
Y48.0 Inhaled anaesthetics	0.007	0.992	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.007	0.993	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.007	0.993	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.993	0.000
Y53.7 Emetics	0.007	0.993	0.000
Y53.5 Digestants	0.007	0.993	0.000
Y53.0 Histamine H2-receptor antagonists	0.007	0.993	0.000
Y53.4 Other laxatives	0.007	0.993	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.007	0.993	0.000
Y55.5 Anticommon cold drugs	0.007	0.993	0.000
Y55.4 Expectorants	0.007	0.993	0.000
Y55.3 Antitussives	0.007	0.993	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.007	0.993	0.000
Y55.0 Oxytocic drugs	0.007	0.993	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.000	0.993	0.007
Y49.0 Tricyclic and tetracyclic antidepressants	0.007	0.993	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.007	0.993	0.000
Y48.2 Other and unspecified general anaesthetics	0.007	0.993	0.000
Y49.9 Psychotropic drug, unspecified	0.007	0.993	0.000
Y49.7 Psychostimulants with abuse potential	0.007	0.993	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.007	0.993	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
Y50.9 Central nervous system stimulant, unspecified	0.007	0.993	0.000
Y50.8 Other central nervous system stimulants	0.007	0.993	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.007	0.993	0.000
Y50.1 Opioid receptor antagonists	0.007	0.993	0.000
Y50.0 Analeptics	0.007	0.993	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.007	0.993	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.006	0.993	0.000
Y57.7 Vitamins, not elsewhere classified	0.006	0.994	0.000
Y57.4 Pharmaceutical excipients	0.006	0.994	0.000
Y57.3 Alcohol deterrents	0.006	0.994	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
Y57.1 Lipotropic drugs	0.006	0.994	0.000
Y57.0 Appetite depressants [anorectics]	0.006	0.994	0.000
Y58.9 Other and unspecified bacterial vaccines	0.006	0.994	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.006	0.994	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.006	0.994	0.000
Y58.5 Diphtheria vaccine	0.006	0.994	0.000
Y58.4 Tetanus vaccine	0.006	0.994	0.000
Y58.3 Plague vaccine	0.006	0.994	0.000
Y58.2 Cholera vaccine	0.006	0.994	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.006	0.994	0.000
Y56.9 Topical agent, unspecified	0.006	0.994	0.000
Y56.8 Other topical agents	0.006	0.994	0.000
Y56.7 Dental drugs, topically applied	0.006	0.994	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.006	0.994	0.000
Y56.5 Ophthalmological drugs and preparations	0.006	0.994	0.000
Y56.3 Emollients, demulcents and protectants	0.006	0.994	0.000
Y56.2 Local astringents and local detergents	0.006	0.994	0.000
Y56.1 Antipruritics	0.006	0.994	0.000
Y57.6 Other diagnostic agents	0.006	0.994	0.000
Y49.5 Other antipsychotics and neuroleptics	0.006	0.994	0.000
F01.9 Vascular dementia, unspecified	0.006	0.994	0.000
O26.8 Other specified pregnancy-related conditions	0.000	0.994	0.006
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.006	0.994	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.006	0.994	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.006	0.994	0.000
Y47.4 Bromine compounds	0.006	0.994	0.000
Y47.3 Paraldehyde	0.006	0.994	0.000
Y47.2 Chloral derivatives	0.006	0.994	0.000
Y47.0 Barbiturates, not elsewhere classified	0.006	0.994	0.000
E21.0 Primary hyperparathyroidism	0.006	0.994	0.000
Y41.1 Antimycobacterial drugs	0.006	0.994	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
Y58.0 BCG vaccine	0.005	0.994	0.000
Y57.8 Other drugs and medicaments	0.006	0.994	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.005	0.994	0.000
Y41.4 Anthelminthics	0.005	0.994	0.000
Y41.3 Other antiprotozoal drugs	0.005	0.994	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.005	0.994	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.006	0.994	0.000
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.005	0.995	0.000
K07.3 Anomalies of tooth position	0.000	0.995	0.005
Y41.5 Antiviral drugs	0.005	0.995	0.000
Y49.2 Other and unspecified antidepressants	0.005	0.995	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.005	0.995	0.000
E14.3 With ophthalmic complications	0.005	0.995	0.000
T23.0 Burn of unspecified degree of wrist and hand	0.005	0.995	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.005	0.995	0.000
T23 Burn and corrosion of wrist and hand	0.005	0.995	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.995	0.005
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.005	0.995	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.005	0.995	0.000
K07.2 Anomalies of dental arch relationship	0.000	0.995	0.005
K07 Dentofacial anomalies [including malocclusion]	0.000	0.995	0.005
Y43 Primarily systemic agents	0.005	0.995	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y45.2 Propionic acid derivatives	0.005	0.995	0.000
T21.0 Burn of unspecified degree of trunk	0.005	0.995	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.005	0.995	0.000
T21 Burn and corrosion of trunk	0.005	0.995	0.000
T25 Burn and corrosion of ankle and foot	0.005	0.995	0.000
Y57.9 Drug or medicament, unspecified	0.005	0.995	0.000
Y41.0 Sulphonamides	0.004	0.995	0.000
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.005	0.995	0.000
Y45.8 Other analgesics and antipyretics	0.005	0.995	0.000
Y47.1 Benzodiazepines	0.004	0.995	0.000
R30.9 Painful micturition, unspecified	0.005	0.995	0.000
Y54.7 Agents affecting calcification	0.004	0.995	0.000
K07.4 Malocclusion, unspecified	0.000	0.995	0.004
T20 Burn and corrosion of head and neck	0.004	0.996	0.000
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
T23.1 Burn of first degree of wrist and hand	0.004	0.996	0.000
Y45.4 Antirheumatics	0.004	0.996	0.000
K07.1 Anomalies of jaw-cranial base relationship	0.000	0.996	0.004
Y45.1 Salicylates	0.004	0.996	0.000
T20.3 Burn of third degree of head and neck	0.004	0.996	0.000
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.004	0.996	0.000
K07.0 Major anomalies of jaw size	0.000	0.996	0.004
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.004	0.996	0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.004	0.996	0.000
Y43.2 Antineoplastic natural products	0.004	0.996	0.000
T23.3 Burn of third degree of wrist and hand	0.004	0.996	0.000
T25.2 Burn of second degree of ankle and foot	0.004	0.996	0.000
Y54.9 Mineral salts, not elsewhere classified	0.004	0.996	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.004	0.996	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.004	0.996	0.000
Y54.0 Mineralocorticoids	0.004	0.996	0.000
T23.7 Corrosion of third degree of wrist and hand	0.004	0.996	0.000
T23.6 Corrosion of second degree of wrist and hand	0.004	0.996	0.000
T23.5 Corrosion of first degree of wrist and hand	0.004	0.996	0.000
T23.4 Corrosion of unspecified degree of wrist and hand	0.004	0.996	0.000
Y43.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
Y54.5 Other diuretics	0.004	0.996	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.004	0.996	0.000
T20.1 Burn of first degree of head and neck	0.004	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.004	0.996	0.000
H54.0 Blindness, both eyes	0.004	0.996	0.000
K07.8 Other dentofacial anomalies	0.000	0.996	0.004
K07.5 Dentofacial functional abnormalities	0.000	0.996	0.004
K07.6 Temporomandibular joint disorders	0.000	0.996	0.004
H25.9 Senile cataract, unspecified	0.004	0.996	0.000
T80.2 Infections following infusion, transfusion and therapeutic injection	0.004	0.996	0.000
Y43.9 Primarily systemic agent, unspecified	0.004	0.996	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.004	0.996	0.000
Y43.6 Enzymes, not elsewhere classified	0.004	0.996	0.000
Y43.5 Acidifying and alkalising agents	0.004	0.996	0.000
T25.3 Burn of third degree of ankle and foot	0.004	0.996	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.004	0.996	0.000
C18.6 Descending colon	0.000	0.996	0.004
T21.3 Burn of third degree of trunk	0.004	0.996	0.000
T24.7 Corrosion of third degree of hip and lower limb, except ankle and foot	0.004	0.996	0.000
T24.6 Corrosion of second degree of hip and lower limb, except ankle and foot	0.004	0.996	0.000
T24.5 Corrosion of first degree of hip and lower limb, except ankle and foot	0.004	0.996	0.000
T24.4 Corrosion of unspecified degree of hip and lower limb, except ankle and foot	0.004	0.996	0.000
K07.9 Dentofacial anomaly, unspecified	0.000	0.996	0.004
T21.7 Corrosion of third degree of trunk	0.003	0.996	0.000
T21.6 Corrosion of second degree of trunk	0.003	0.996	0.000
T21.5 Corrosion of first degree of trunk	0.003	0.996	0.000
T21.4 Corrosion of unspecified degree of trunk	0.003	0.996	0.000
T25.7 Corrosion of third degree of ankle and foot	0.003	0.996	0.000
T25.6 Corrosion of second degree of ankle and foot	0.003	0.996	0.000
T25.5 Corrosion of first degree of ankle and foot	0.003	0.996	0.000
T25.4 Corrosion of unspecified degree of ankle and foot	0.003	0.996	0.000
T25.1 Burn of first degree of ankle and foot	0.003	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.996	0.004
T23.2 Burn of second degree of wrist and hand	0.003	0.996	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.996	0.000
H54 Blindness and low vision	0.004	0.996	0.000
T24.3 Burn of third degree of hip and lower limb, except ankle and foot	0.003	0.996	0.000
F01 Vascular dementia	0.004	0.996	0.000
T25.0 Burn of unspecified degree of ankle and foot	0.003	0.996	0.000
T20.7 Corrosion of third degree of head and neck	0.003	0.997	0.000
T20.6 Corrosion of second degree of head and neck	0.003	0.997	0.000
T20.5 Corrosion of first degree of head and neck	0.003	0.997	0.000
T20.4 Corrosion of unspecified degree of head and neck	0.003	0.997	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.003	0.997	0.000
H54.9 Unspecified visual impairment (binocular)	0.003	0.997	0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
T21.1 Burn of first degree of trunk	0.003	0.997	0.000
S89.8 Other specified injuries of lower leg	0.000	0.997	0.003
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
R79.0 Abnormal level of blood mineral	0.003	0.997	0.000
C43.9 Malignant melanoma of skin, unspecified	0.000	0.997	0.003
C43.4 Malignant melanoma of scalp and neck	0.000	0.997	0.003
N76.2 Acute vulvitis	0.000	0.997	0.003
I98 Other disorders of circulatory system in diseases classified elsewhere	0.003	0.997	0.000
H54.7 Unspecified visual loss	0.003	0.997	0.000
H54.3 Unqualified visual loss, both eyes	0.003	0.997	0.000
H54.2 Low vision, both eyes	0.003	0.997	0.000
F01.1 Multi-infarct dementia	0.003	0.997	0.000
C43 Malignant melanoma of skin	0.000	0.997	0.003
O68 Labour and delivery complicated by foetal stress [distress]	0.000	0.997	0.003
T20.2 Burn of second degree of head and neck	0.003	0.997	0.000
T21.2 Burn of second degree of trunk	0.003	0.997	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.997	0.003
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.997	0.001
Z43.3 Attention to colostomy	0.000	0.997	0.003
M79.88 Other specified soft tissue disorders (Other)	0.003	0.997	0.000
F01.8 Other vascular dementia	0.003	0.997	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.003	0.997	0.000
F01.2 Subcortical vascular dementia	0.003	0.997	0.000
F01.0 Vascular dementia of acute onset	0.003	0.997	0.000
H54.6 Unqualified visual loss, one eye	0.003	0.997	0.000
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.000	0.997	0.003
H54.4 Blindness, one eye	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
R55 Syncope and collapse	0.003	0.997	0.000
M54.17 Radiculopathy (Lumbosacral region)	0.003	0.997	0.000
T20.0 Burn of unspecified degree of head and neck	0.002	0.997	0.000
C43.2 Malignant melanoma of ear and external auricular canal	0.000	0.997	0.003
H54.5 Low vision, one eye	0.002	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.997	0.000
E10.1 With ketoacidosis	0.003	0.997	0.000
H54.1 Blindness, one eye, low vision, other eye	0.002	0.997	0.000
K65.9 Peritonitis, unspecified	0.000	0.997	0.003
Y43.4 Immunosuppressive agents	0.002	0.997	0.000
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.002	0.997	0.000
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
I98.0 Cardiovascular syphilis	0.002	0.997	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.997	0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.997	0.002
E14 Unspecified diabetes mellitus	0.003	0.997	0.000
M19.03 Primary arthrosis of other joints (Forearm)	0.000	0.997	0.002
K56.7 Ileus, unspecified	0.000	0.997	0.002
K55.2 Angiodysplasia of colon	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.002	0.998	0.000
C43.8 Overlapping malignant melanoma of skin	0.000	0.998	0.002
C43.0 Malignant melanoma of lip	0.000	0.998	0.002
E14.4 With neurological complications	0.002	0.998	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.998	0.002
C71.9 Brain, unspecified	0.000	0.998	0.002
E10.5 With peripheral circulatory complications	0.002	0.998	0.000
E10.4 With neurological complications	0.002	0.998	0.000
E10 Insulin-dependent diabetes mellitus	0.002	0.998	0.000
I86.8 Varicose veins of other specified sites	0.002	0.998	0.000
N42.9 Disorder of prostate, unspecified	0.000	0.998	0.002
N76.3 Subacute and chronic vulvitis	0.000	0.998	0.002
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
E10.6 With other specified complications	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
N43.3 Hydrocele, unspecified	0.002	0.998	0.000
E14.6 With other specified complications	0.002	0.998	0.000
E10.7 With multiple complications	0.002	0.998	0.000
E23.2 Diabetes insipidus	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
E14.1 With ketoacidosis	0.002	0.998	0.000
E10.0 With coma	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
E14.7 With multiple complications	0.002	0.998	0.000
E14.0 With coma	0.002	0.998	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.002	0.998	0.000
E14.8 With unspecified complications	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
F60.6 Anxious [avoidant] personality disorder	0.000	0.998	0.002
F60 Specific personality disorders	0.000	0.998	0.002
F60.0 Paranoid personality disorder	0.000	0.998	0.002
I22.8 Subsequent myocardial infarction of other sites	0.002	0.998	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.998	0.000
S22.30 Fracture of rib (closed)	0.000	0.998	0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
M19.0 Primary arthrosis of other joints	0.000	0.998	0.002
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.002	0.998	0.000
F60.7 Dependent personality disorder	0.000	0.998	0.002
N76.1 Subacute and chronic vaginitis	0.000	0.998	0.002
M79.83 Other specified soft tissue disorders (Forearm)	0.002	0.998	0.000
A87.9 Viral meningitis, unspecified	0.002	0.998	0.000
E14.5 With peripheral circulatory complications	0.002	0.998	0.000
E14.2 Withrenal complications	0.002	0.998	0.000
F05.0 Delirium not superimposed on dementia, so described	0.002	0.998	0.000
S59.9 Unspecified injury of forearm	0.002	0.998	0.000
T91.1 Sequelae of fracture of spine	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.002	0.998	0.000
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.000	0.998	0.002
E10.2 With renal complications	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
N76 Other inflammation of vagina and vulva	0.000	0.998	0.002
N76.5 Ulceration of vagina	0.000	0.998	0.002
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
K75.4 Autoimmune hepatitis	0.000	0.998	0.002
T91.3 Sequelae of injury of spinal cord	0.002	0.998	0.000
C71.2 Temporal lobe	0.000	0.998	0.002
F60.5 Anankastic personality disorder	0.000	0.998	0.002
F60.9 Personality disorder, unspecified	0.000	0.998	0.002
F60.3 Emotionally unstable personality disorder	0.000	0.998	0.002
I80 Phlebitis and thrombophlebitis	0.002	0.998	0.000
H53-H54 Visual disturbances and blindness	0.002	0.998	0.000
H27.0 Aphakia	0.002	0.998	0.000
S89 Other and unspecified injuries of lower leg	0.000	0.998	0.002
H53.9 Visual disturbance, unspecified	0.002	0.998	0.000
F05.8 Other delirium	0.002	0.998	0.000
I15.1 Hypertension secondary to other renal disorders	0.002	0.998	0.000
Z71.6 Tobacco abuse counselling	0.002	0.998	0.000
C43.5 Malignant melanoma of trunk	0.000	0.998	0.002
F60.4 Histrionic personality disorder	0.000	0.998	0.002
F60.1 Schizoid personality disorder	0.000	0.998	0.002
N19 Unspecified renal failure	0.000	0.998	0.002
M79.82 Other specified soft tissue disorders (Upper arm)	0.002	0.998	0.000
F80.1 Expressive language disorder	0.000	0.998	0.002
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.002	0.998	0.000
L29.2 Pruritus vulvae	0.000	0.998	0.002
R50.0 Fever with chills	0.002	0.998	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.002	0.998	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.002	0.998	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.002	0.998	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.998	0.002
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.000	0.998	0.002
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.998	0.002
E10.3 With ophthalmic complications	0.002	0.998	0.000
F60.8 Other specific personality disorders	0.000	0.998	0.002
M79.8 Other specified soft tissue disorders	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.998	0.000
S89.9 Unspecified injury of lower leg	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
D17.9 Benign lipomatous neoplasm, unspecified	0.000	0.998	0.002
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
Q23.1 Congenital insufficiency of aortic valve	0.000	0.998	0.002
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
M21.24 Flexion deformity (Hand)	0.000	0.998	0.002
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.002	0.998	0.000
F60.2 Dissocial personality disorder	0.000	0.998	0.001
Y52.1 Calcium-channel blockers	0.001	0.998	0.000
C71 Malignant neoplasm of brain	0.000	0.998	0.002
E10.8 With unspecified complications	0.001	0.998	0.000
H53.8 Other visual disturbances	0.002	0.998	0.000
H53 Visual disturbances	0.002	0.998	0.000
M79.84 Other specified soft tissue disorders (Hand)	0.002	0.998	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.998	0.002
T91.9 Sequelae of unspecified injury of neck and trunk	0.002	0.998	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.998	0.002
K76.6 Portal hypertension	0.002	0.998	0.000
M20.3 Other deformity of hallux (acquired)	0.000	0.998	0.002
E21.4 Other specified disorders of parathyroid gland	0.001	0.998	0.000
E21.2 Other hyperparathyroidism	0.001	0.998	0.000
Y40.6 Rifamycins	0.001	0.998	0.000
S89.7 Multiple injuries of lower leg	0.000	0.998	0.001
S89.1 Other specified injuries of lower leg	0.000	0.998	0.001
S89.0 Multiple injuries of lower leg	0.000	0.998	0.001
T94.1 Sequelae of injuries, not specified by body region	0.002	0.998	0.000
N93 Other abnormal uterine and vaginal bleeding	0.002	0.998	0.000
S90.9 Superficial injury of ankle and foot, unspecified	0.002	0.998	0.000
W15.8 Other specified place	0.000	0.998	0.002
M19.08 Primary arthrosis of other joints (Other)	0.000	0.998	0.001
D18.1 Lymphangioma, any site	0.002	0.998	0.000
F05.1 Delirium superimposed on dementia	0.001	0.998	0.000
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.000	0.998	0.002
T91.2 Sequelae of other fracture of thorax and pelvis	0.001	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
C71.8 Overlapping lesion of brain	0.000	0.998	0.001
H53.2 Diplopia	0.002	0.998	0.000
M71.2 Synovial cyst of popliteal space [Baker]	0.001	0.998	0.000
Y40.5 Aminoglycosides	0.001	0.998	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
D28.0 Vulva	0.000	0.998	0.001
Q76.4 Other congenital malformations of spine, not associated with scoliosis	0.001	0.998	0.000
Y40.3 Macrolides	0.001	0.998	0.000
R79 Other abnormal findings of blood chemistry	0.002	0.998	0.000
N76.8 Other specified inflammation of vagina and vulva	0.000	0.999	0.001
Q07.0 Arnold-Chiari syndrome	0.000	0.999	0.001
E10-E14 Diabetes mellitus	0.001	0.999	0.000
C71.5 Cerebral ventricle	0.000	0.999	0.001
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.999	0.001
H53.6 Night blindness	0.001	0.999	0.000
H53.5 Colour vision deficiencies	0.001	0.999	0.000
H53.3 Other disorders of binocular vision	0.001	0.999	0.000
M71.81 Other specified bursopathies (Shoulder region)	0.001	0.999	0.000
M79.81 Other specified soft tissue disorders (Shoulder region)	0.001	0.999	0.000
C45.9 Mesothelioma, unspecified	0.000	0.999	0.001
C71.6 Cerebellum	0.000	0.999	0.001
I82.2 Embolism and thrombosis of vena cava	0.001	0.999	0.000
C71.7 Brain stem	0.000	0.999	0.001
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.001	0.999	0.000
M19.06 Primary arthrosis of other joints-Lower leg	0.000	0.999	0.001
C26.0 Intestinal tract, part unspecified	0.000	0.999	0.001
C71.3 Parietal lobe	0.000	0.999	0.001
C71.0 Cerebrum, except lobes and ventricles	0.000	0.999	0.001
D23.9 Skin, unspecified	0.000	0.999	0.001
G82.5 Tetraplegia, unspecified	0.001	0.999	0.000
N76.4 Abscess of vulva	0.000	0.999	0.001
T82.0 Mechanical complication of heart valve prosthesis	0.000	0.999	0.001
M79.79 Fibromyalgia (Site unspecified)	0.001	0.999	0.000
N76.6 Ulceration of vulva	0.000	0.999	0.001
Q75.4 Mandibulofacial dysostosis	0.001	0.999	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.000	0.999	0.001
M19.00 Primary arthrosis of other joints (Multiple sites)	0.000	0.999	0.001
M71.29 Synovial cyst of popliteal space [Baker]-Site unspec	0.001	0.999	0.000
M71.28 Synovial cyst of popliteal space [Baker]-Other	0.001	0.999	0.000
M71.27 Synovial cyst of popliteal space [Baker]-Ankle/Foot	0.001	0.999	0.000
M71.25 Synovial cyst of popliteal space [Baker]-Pelvic/Thigh	0.001	0.999	0.000
M71.24 Synovial cyst of popliteal space [Baker]-Hand	0.001	0.999	0.000
M71.23 Synovial cyst of popliteal space [Baker]-Forearm	0.001	0.999	0.000
M71.22 Synovial cyst of popliteal space [Baker]-Upper arm	0.001	0.999	0.000
M71.21 Synovial cyst of popliteal space [Baker]-Shldr region	0.001	0.999	0.000
M71.20 Synovial cyst of popliteal space [Baker]-Mult sites	0.001	0.999	0.000
M79.63 Pain in limb (Forearm)	0.001	0.999	0.000
M79.89 Other specified soft tissue disorders (Site unspecified)	0.001	0.999	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.001	0.999	0.000
A87.0 Enteroviral meningitis	0.001	0.999	0.000
R87.9 Unspecified abnormal finding	0.000	0.999	0.001
Y79.2 Prosthetic and other implants, materials and accessory devices	0.000	0.999	0.001
A87 Viral meningitis	0.001	0.999	0.000
M19.01 Primary arthrosis of other joints (Shoulder region)	0.000	0.999	0.001
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.001	0.999	0.000
E13 Other specified diabetes mellitus	0.001	0.999	0.000
K55 Vascular disorders of intestine	0.000	0.999	0.001
C77.5 Intrapelvic lymph nodes	0.001	0.999	0.000
H53.4 Visual field defects	0.001	0.999	0.000
I15.2 Hypertension secondary to endocrine disorders	0.001	0.999	0.000
T90.5 Sequelae of intracranial injury	0.000	0.999	0.001
W22.3 Sports and athletics area	0.001	0.999	0.000
Y40.9 Systemic antibiotic, unspecified	0.001	0.999	0.000
E12 Malnutrition-related diabetes mellitus	0.001	0.999	0.000
M76.86 Other enthesopathies of lower limb, excluding foot (Lower leg)	0.001	0.999	0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations